0001181431-12-007984.txt : 20120213 0001181431-12-007984.hdr.sgml : 20120213 20120213063341 ACCESSION NUMBER: 0001181431-12-007984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120201 FILED AS OF DATE: 20120213 DATE AS OF CHANGE: 20120213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZUERBLIS KENNETH J CENTRAL INDEX KEY: 0001007923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12595113 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE RD CITY: PISCATAWAY STATE: NJ ZIP: 08854 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd333863.xml X0304 4 2012-02-01 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001007923 ZUERBLIS KENNETH J ONE TOWER CENTER BLVD. 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 EVP, Chief Financial Officer Option to Purchase Common Stock, $.01 par value 2.26 2012-02-01 4 A 0 100000 2.26 A 2013-02-01 2022-02-01 Common Stock, $.01 par value per share 100000 100000 D These options vest as to one-third on each of the first three anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates. /s/ Irina Ishak for Kenneth Zuerblis 2012-02-13